Erythromycin estolate hepatotoxicity. 1978

J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D004918 Erythromycin Estolate A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erythromycin Propionate Dodecyl Sulfate,Erythromycin Propionate Lauryl Sulfate,Eromycin,Erythromycin Propionate Monododecyl Sulfate,Ilosone,Lauromicina,Estolate, Erythromycin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
December 1992, Atencion primaria,
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
August 1982, Digestive diseases and sciences,
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
November 1977, Antimicrobial agents and chemotherapy,
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
May 2004, Pharmacological research,
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
January 2003, Therapie,
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
January 1974, JAMA,
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
January 1984, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
July 1988, Lancet (London, England),
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
June 1983, British medical journal (Clinical research ed.),
J D Lloyd-Still, and J O Sherman, and J Boggs, and L M Demers
August 1997, Journal of ethnopharmacology,
Copied contents to your clipboard!